Menu
Back to Browse Categories
Related journals you may be interested in:
Recent articles:
- 10 records -
Prevalence of Oral Helicobacter pylori Infection in an Indigenous Community in Southwest Mexico
Urrutia-Baca VH, Gonzalez Brosig KI, Salazar-Garza AA, Gomez-Flores R, Tamez-Guerra P, De La Garza-Ramos MA
Clinical and Experimental Gastroenterology 2023, 16:173-180
Published Date: 21 September 2023
Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver Diseases
Ait Ahmed Y, Lafdil F, Tacke F
Hepatic Medicine: Evidence and Research 2023, 15:113-127
Published Date: 21 September 2023
Improved Survival in At-Risk Patients Undergoing Surveillance for Hepatocellular Carcinoma – A Nationwide Swedish Register-Based Study
Thörn R, Hemmingsson O, Danielsson Borssén Å, Werner M, Karling P, Wixner J
Journal of Hepatocellular Carcinoma 2023, 10:1573-1586
Published Date: 19 September 2023
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma
Omar A, Kaseb A, Elbaz T, El-Kassas M, El Fouly A, Hanno AF, El Dorry A, Hosni A, Helmy A, Saad AS, Alolayan A, Eysa BE, Hamada E, Azim H, Khattab H, Elghazaly H, Tawfik H, Ayoub H, Khaled H, Saadeldin I, Waked I, Barakat EMF, El Meteini M, Hamed Shaaban M, EzzElarab M, Fathy M, Shaker M, Sobhi M, Shaker MK, ElGharib M, Abdullah M, Mokhtar M, Elshazli M, Heikal OMK, Hetta O, ElWakil RM, Abdel Wahab S, Eid SS, Rostom Y
Journal of Hepatocellular Carcinoma 2023, 10:1547-1571
Published Date: 18 September 2023
Al-Hijamah (Prophetic Wet Cupping Therapy) is a Novel Adjuvant Treatment for Viral Hepatitis That Excretes Viral Particles and Excess Ferritin Percutaneously, Synergizes Pharmacotherapy, Enhances Antiviral Immunity and Helps Better HCC Prevention and Treatment: A Novel Evidence-Based Combination with Prophetic Medicine Remedies
El Sayed SM
Journal of Hepatocellular Carcinoma 2023, 10:1527-1546
Published Date: 13 September 2023
Efficacy of TACE Combined with Lenvatinib Plus Sintilimab for Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava and/or Right Atrium
Ning S, Li X, Ma X, Liu J, Chang X
Journal of Hepatocellular Carcinoma 2023, 10:1511-1525
Published Date: 13 September 2023
N6-Methyladenosine-Modified ATP8B1-AS1 Exerts Oncogenic Roles in Hepatocellular Carcinoma via Epigenetically Activating MYC
Tan C, Huang Y, Huang Z, Ning Y, Huang L, Wu X, Lu Y, Wei H, Pu J
Journal of Hepatocellular Carcinoma 2023, 10:1479-1495
Published Date: 6 September 2023
Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
Ouyang J, Wang Z, Yuan K, Yang Y, Zhou Y, Li Q, Yang N, Zhao H, Zhao H, Zhou J
Journal of Hepatocellular Carcinoma 2023, 10:1465-1477
Published Date: 6 September 2023
Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study
Chang X, Wu H, Ning S, Li X, Xie Y, Shao W, Yu J
Journal of Hepatocellular Carcinoma 2023, 10:1497-1509
Published Date: 6 September 2023
Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma
Carloni R, Sabbioni S, Rizzo A, Ricci AD, Palloni A, Petrarota C, Cusmai A, Tavolari S, Gadaleta-Caldarola G, Brandi G
Journal of Hepatocellular Carcinoma 2023, 10:1445-1463
Published Date: 6 September 2023